Female Hormone Therapy Online: Estrogen, Progesterone, and What to Know Before Starting

Women go through perimenopause and menopause. Most doctors spend an average of three minutes discussing it at wellness visits. The result: millions of women experiencing significant quality-of-life impacts from hormone decline who don't know effective treatment exists — or who can't easily access it.

This is starting to change. Here's the honest guide to female hormone therapy, including what it treats, who it's appropriate for, and how to access it.

The Hormone Decline Timeline

Perimenopause typically begins in the mid-40s (sometimes as early as 35) and lasts an average of 4-10 years. It's characterized by erratic hormone fluctuations — estrogen and progesterone don't decline steadily; they swing unpredictably. This is why perimenopause often feels chaotic:

• Sleep disruption despite exhaustion
• Anxiety or mood swings that seem disproportionate
• Irregular periods — longer, shorter, heavier, lighter
• Hot flashes and night sweats (vasomotor symptoms)
• Brain fog and memory issues
• Joint aches
• Changes in libido and vaginal dryness

Menopause is technically defined as 12 consecutive months without a period, typically occurring around age 51. After this point, estrogen and progesterone levels stabilize at a consistently low level.

Postmenopause is everything after. Without intervention, low estrogen increases risk of: cardiovascular disease, osteoporosis, vaginal atrophy, urinary symptoms, and cognitive decline.

The Evidence for HRT

The Women's Health Initiative (WHI) trial in 2002 created a generation of women and physicians afraid of hormone therapy. That fear deserves to be challenged with what we've learned since.

The WHI study had significant methodology problems: it enrolled women who were, on average, 63 years old — well past the optimal window for HRT initiation. The formulations used were older synthetic versions (conjugated equine estrogens + medroxyprogesterone acetate), not the bioidentical hormones most commonly used today.

Re-analysis and subsequent research has established the "timing hypothesis": HRT started within 10 years of menopause onset and under age 60 has a favorable risk-benefit profile for most women. Benefits include:

• Significant reduction in vasomotor symptoms (hot flashes, night sweats)
• Preserved bone density (HRT is one of the most effective osteoporosis prevention strategies available)
• Cardiovascular protection when started early
• Improved sleep quality
• Cognitive protection — emerging evidence suggests early HRT may reduce dementia risk
• Improved mood and reduced depression symptoms
• Better sexual function and reduced vaginal atrophy

What Hormone Therapy Actually Looks Like

Estrogen (estradiol): The primary replacement. Available as: - Patches (Vivelle, Climara) — changed 1-2x per week - Gels or creams (EstroGel, Divigel) — applied daily to skin - Oral tablets — less preferred due to first-pass liver metabolism increasing clotting risk - Vaginal cream or ring — local treatment for vaginal symptoms

Transdermal estradiol (patch, gel) is generally preferred over oral because it bypasses liver metabolism, produces more stable levels, and has lower thromboembolism risk.

Progesterone (or progestogen): Any woman with an intact uterus needs progesterone alongside estrogen — unopposed estrogen increases endometrial cancer risk. Bioidentical progesterone (Prometrium) is preferred over synthetic progestins for its better safety profile and protective effect on breast tissue.

Women who have had a hysterectomy can use estrogen alone.

Testosterone: An often-overlooked component. Women produce testosterone in the ovaries, and levels decline with menopause. Low testosterone in women manifests as reduced libido, fatigue, and reduced muscle mass. Low-dose testosterone supplementation (typically 5-10% of male doses) can address these symptoms. It's off-label but well-supported by evidence.

Who Should Consider HRT

Good candidates: - Women experiencing significant perimenopausal or menopausal symptoms impacting quality of life - Women under 60 or within 10 years of menopause onset - Women at risk for osteoporosis - Women who had surgical menopause (oophorectomy) — these patients especially benefit and are typically started on HRT immediately

Who should proceed with caution or avoid: - History of estrogen receptor-positive breast cancer (requires careful shared decision-making with oncologist) - History of blood clots or clotting disorder (oral estrogen increases risk; transdermal doesn't significantly) - Active liver disease - Uncontrolled hypertension (treat first, then assess HRT candidacy) - History of stroke or heart attack within the past year

Accessing HRT Online

The telehealth model is particularly valuable for women seeking hormone therapy, because:

1. Finding a physician comfortable with modern HRT evidence takes effort — many PCPs haven't updated their approach since the 2002 WHI scare
2. Specialist waits (OB/GYN) can be months long
3. The evaluation is straightforward and doesn't require physical examination in most cases

The online intake covers: symptom severity, menstrual history, personal and family history of breast cancer and blood clots, cardiovascular history, and current medications. Labs may be ordered depending on the clinical picture.

[Marrow's women's health program](/treatments) provides access to physician-managed hormone therapy with ongoing monitoring. [Start your intake](/start) for physician review within 24 hours.